Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Iovance Biotherapeutics, Inc. IOVA

Full chart Compare
Set alert

Price alert · IOVA

All alert types
8.04 USD +0.30 (+3.88%)

At closeNov 9, 2026, 7:07 AM EST

8.01 -0.03 -0.37%

Pre-market · Nov 9, 7:07 AM ET

7.72 Day range 8.28
2.08 52-week range 15.37
YTD
+194.51%
1 year
+248.05%

Financial health

Altman Z-Score

8.27 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E -2.5×
FY 2016: -7.2×FY 2017: -5.7×FY 2018: -7.0×FY 2019: -18.5×FY 2020: -24.7×FY 2021: -8.6×FY 2022: -2.6×FY 2023: -4.3×FY 2024: -5.8×FY 2025: -2.5×
FY 2016 5y median -4.3× FY 2025
P/S 3.7×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 1608×FY 2024: 13.1×FY 2025: 3.7×
FY 2016 5y median 3.7× FY 2025
P/B 1.4×
FY 2016: 2.3×FY 2017: 3.6×FY 2018: 1.8×FY 2019: 11.5×FY 2020: 9.8×FY 2021: 4.7×FY 2022: 2.0×FY 2023: 3.3×FY 2024: 3.0×FY 2025: 1.4×
FY 2016 5y median 3.0× FY 2025
P/FCF -2.9×
FY 2016: -11.2×FY 2017: -6.5×FY 2018: -8.4×FY 2019: -20.8×FY 2020: -25.5×FY 2021: -11.0×FY 2022: -3.2×FY 2023: -5.0×FY 2024: -5.9×FY 2025: -2.9×
FY 2016 5y median -5.0× FY 2025
EV/EBITDA -2.5×
FY 2016: -4.2×FY 2017: -4.1×FY 2018: -6.4×FY 2019: -18.2×FY 2020: -24.5×FY 2021: -8.9×FY 2022: -2.3×FY 2023: -4.5×FY 2024: -6.3×FY 2025: -2.5×
FY 2016 5y median -4.5× FY 2025
EV/Sales 3.3×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 1575×FY 2024: 12.7×FY 2025: 3.3×
FY 2016 5y median 3.3× FY 2025
FCF Yield -34.5%
FY 2016: -8.9%FY 2017: -15.3%FY 2018: -11.9%FY 2019: -4.8%FY 2020: -3.9%FY 2021: -9.1%FY 2022: -30.8%FY 2023: -20.1%FY 2024: -17.0%FY 2025: -34.5%
FY 2016 5y median -20.1% FY 2025

Profitability

Gross Margin 34.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -804.5%FY 2024: 24.4%FY 2025: 34.3%
FY 2016 5y median 0.0% FY 2025
Operating Margin -151.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -38735.0%FY 2024: -240.9%FY 2025: -151.1%
FY 2016 5y median -151.1% FY 2025
Net Margin -148.4%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -37345.4%FY 2024: -226.8%FY 2025: -148.4%
FY 2016 5y median -148.4% FY 2025
ROE -56.0%
FY 2016: -31.7%FY 2017: -63.3%FY 2018: -26.5%FY 2019: -66.1%FY 2020: -39.5%FY 2021: -55.1%FY 2022: -79.2%FY 2023: -76.0%FY 2024: -52.4%FY 2025: -56.0%
FY 2016 5y median -56.0% FY 2025
ROIC -50.9%
FY 2016: -32.1%FY 2017: -63.8%FY 2018: -27.5%FY 2019: -66.1%FY 2020: -36.4%FY 2021: -49.4%FY 2022: -68.2%FY 2023: -67.4%FY 2024: -49.0%FY 2025: -50.9%
FY 2016 5y median -50.9% FY 2025
ROA -42.8%
FY 2016: -30.8%FY 2017: -59.3%FY 2018: -25.7%FY 2019: -57.3%FY 2020: -33.8%FY 2021: -44.0%FY 2022: -59.6%FY 2023: -56.9%FY 2024: -40.9%FY 2025: -42.8%
FY 2016 5y median -44.0% FY 2025

Growth (YoY)

Revenue 60.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 13699.0%FY 2025: 60.6%
FY 2016 FY 2025
Operating Income -0.7%
FY 2016: -92.5%FY 2017: -73.2%FY 2018: -38.1%FY 2019: -61.3%FY 2020: -26.6%FY 2021: -30.8%FY 2022: -16.4%FY 2023: -15.5%FY 2024: 14.2%FY 2025: -0.7%
FY 2016 FY 2025
EPS (diluted) 14.8%
FY 2016: -54.8%FY 2017: -46.9%FY 2018: 9.9%FY 2019: -18.1%FY 2020: -25.3%FY 2021: -18.6%FY 2022: -11.7%FY 2023: 24.1%FY 2024: 32.3%FY 2025: 14.8%
FY 2016 FY 2025
Free Cash Flow 7.6%
FY 2016: -75.1%FY 2017: -133.2%FY 2018: -28.5%FY 2019: -61.8%FY 2020: -51.9%FY 2021: -5.4%FY 2022: -18.0%FY 2023: -22.6%FY 2024: 5.2%FY 2025: 7.6%
FY 2016 FY 2025

Financial Health

Current Ratio 3.2×
FY 2016: 34.1×FY 2017: 15.1×FY 2018: 33.0×FY 2019: 8.1×FY 2020: 11.6×FY 2021: 5.7×FY 2022: 5.2×FY 2023: 2.8×FY 2024: 3.7×FY 2025: 3.2×
FY 2016 5y median 3.7× FY 2025
Quick Ratio 2.8×
FY 2016: 34.1×FY 2017: 15.1×FY 2018: 33.0×FY 2019: 8.1×FY 2020: 11.6×FY 2021: 5.7×FY 2022: 5.2×FY 2023: 2.7×FY 2024: 3.3×FY 2025: 2.8×
FY 2016 5y median 3.3× FY 2025
Debt / Equity 0.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.2×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 0.3×
FY 2016: 3.2×FY 2017: 1.6×FY 2018: 0.7×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.4×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.3×
FY 2016 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -134×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 12.9%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: -93.5%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31